Share Oruka's ORKA-001 Delivers 61% Complete Skin Clearance in Phase IIb Psoriasis Study

MarketBeat · ORKA · October 26, 2026

Oruka's ORKA-001 Delivers 61% Complete Skin Clearance in Phase IIb Psoriasis Study

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: MarketBeat ↗